Telemedicine based remote monitoring after liver transplantation: Feasible in a select group and a more stringent control of immunosuppression

O.M. Koc*, M. Pierco, K. Remans, T. Van den Hende, J. Verbeek, H. Van Malenstein, S. Van der Merwe, G. Robaeys, D. Monbaliu, J. Pirenne, B. Van den Bosch, F. Dobbels, F. Nevens

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


Telemedicine gained interest in liver transplant patients but focused until now on the early post-operative period. This prospective cohort study assessed feasibility, safety, and clinical beneficial effects of a telemedicine based remote monitoring program (TRMP) for the chronic follow-up of adult liver transplant recipients. Between November 2017 and August 2019, a total of 87 of the 115 selected patients (76%) started the TRMP. Over the 2 years study period, none of the patients switched to standard follow-up: 39/87 (45%) continued to do this autonomously and 48/87 (55%) stopped to report their data personally but communicated their lab values to the nurse. The other 28/115 (11%) patients who did not accept the TRMP continued the standard follow-up. There was no difference in educational level between the three groups. Remote monitoring did not result in an increase in liver graft rejection and need of hospitalization. TRMP was associated with a higher number of tacrolimus level determinations and tacrolimus blood level concentrations could be kept lower. In conclusion, our results show that in patients with a stable clinical condition there is a high willingness to participate in TRMP and that this approach is safe. Remote monitoring allowed a stringent follow-up of tacrolimus levels.
Original languageEnglish
Article numbere14494
Number of pages9
JournalClinical Transplantation
Issue number1
Early online date1 Oct 2021
Publication statusPublished - Jan 2022


  • CARE
  • kidney injury
  • liver transplant
  • remote monitoring
  • tacrolimus levels
  • telemedicine

Cite this